Sparrow Clinical Trials

Ali-Ahmad, M.D. talks to clinical trial patientThe Sparrow Herbert-Herman Cancer Center, which offers the largest set of clinical trial programs in the region, is dedicated to treating all types of cancer and cancer stages. We are proud to be one of the only regional programs accepting Phase 1, Phase 2, and Phase 3 clinical trials. More than 1,200 Sparrow Patients have enrolled in clinical trials at the Sparrow Herbert-Herman Cancer Center, and receive highly specialized care from clinicians. These Patients are among the first to benefit from new cancer treatments. 

There are clinical trials for breast cancer, lung cancer, genitourinary cancer, hematological cancer, gastrointestinal cancer, and rare cancers. These rigorous trials identify drugs that work to stop cancer and treat the cancer Patient.

The Sparrow team is dedicated to advancing cancer treatment and bringing you world-class cancer care. Through our clinical trial program, Sparrow Patients get the top-ranked, multidisciplinary cancer treatment they need while helping to establish new and exciting standards in cancer care. The cancer center is part of a consortium of cancer centers in the state of Michigan with access to a wide variety of clinical trials sponsored by government organizations such as the National Cancer Institute, part of the National Institutes of Health. 

Sparrow was the first community-based hospital in the country to launch the Molecular Tumor Board (MTB) in collaboration with the Massachusetts-based genomics company Foundation One Medicine. The MTB concept has now expanded to more than 100 community hospitals across the country. 

Sparrow is one of the most successful hospitals in the country at registering Patients for the TAPUR study, a unique clinical trial that uses gene sequencing test results to match Patients to a targeted cancer drug. The trial is aimed at attacking cancer at the molecular genetic level of a tumor and could lead to new standard care protocols for all Patients for years to come. It represents a personalized medicine approach that is increasingly used to provide care for individuals and their unique specific needs. Michigan was one of the first states in the country to participate in the trial, the first organized by the American Society of Clinical Oncology. 


Sub Category

Study Name





Learn more about how Sparrow can offer you the best possible care.

Give us a call and we will get you the help you need.